Prothrombin time self-testing
This article was originally published in The Gray Sheet
Payment instructions to local Medicare contractors have been issued, arriving eight months after CMS' coverage decision in September 2001 (1"The Gray Sheet" Oct. 1, 2001, p. 3) and will become effective July 1. Payment levels for procedure code G0249, covering "test materials and equipment," will be released in the July update of the Medicare physician fee schedule...
You may also be interested in...
CMS' Sept. 18 coverage decision for prothrombin time self-testing will provide Medicare reimbursement for the disposable test strips, but not the home-use monitoring equipment, according to the Centers for Medicare & Medicaid Services.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.